{"status": "Succeeded", "recognitionResults": [{"page": 1, "clockwiseOrientation": 359.92, "width": 2201, "height": 1737, "unit": "pixel", "lines": [{"boundingBox": [221, 145, 529, 144, 530, 221, 222, 222], "text": "ACTOS", "words": [{"boundingBox": [226, 148, 530, 146, 528, 224, 229, 223], "text": "ACTOS"}]}, {"boundingBox": [215, 250, 1053, 255, 1052, 335, 214, 330], "text": "Risks, Upsides & Gaps", "words": [{"boundingBox": [221, 255, 453, 255, 452, 330, 220, 326], "text": "Risks,"}, {"boundingBox": [467, 255, 770, 255, 768, 334, 466, 331], "text": "Upsides"}, {"boundingBox": [788, 255, 835, 255, 833, 335, 787, 334], "text": "&"}, {"boundingBox": [863, 255, 1054, 255, 1052, 336, 861, 335], "text": "Gaps"}]}, {"boundingBox": [260, 384, 695, 385, 694, 440, 260, 440], "text": "Potential Risks", "words": [{"boundingBox": [263, 385, 528, 386, 526, 439, 260, 441], "text": "Potential"}, {"boundingBox": [539, 386, 695, 387, 694, 440, 537, 439], "text": "Risks"}]}, {"boundingBox": [281, 462, 865, 461, 866, 508, 282, 509], "text": ">Avandamet 4/1000 launch", "words": [{"boundingBox": [288, 465, 566, 463, 565, 510, 287, 506], "text": ">Avandamet", "confidence": "Low"}, {"boundingBox": [574, 462, 715, 462, 714, 510, 573, 510], "text": "4/1000"}, {"boundingBox": [723, 462, 864, 462, 862, 509, 721, 510], "text": "launch"}]}, {"boundingBox": [280, 523, 1666, 520, 1667, 576, 281, 578], "text": ">Lag behind on SOV and other marketing spending (DTC, etc.) Vs.", "words": [{"boundingBox": [284, 528, 410, 527, 409, 574, 284, 572], "text": ">Lag", "confidence": "Low"}, {"boundingBox": [418, 527, 561, 526, 561, 576, 418, 574], "text": "behind"}, {"boundingBox": [570, 526, 623, 526, 623, 576, 570, 576], "text": "on"}, {"boundingBox": [634, 526, 728, 526, 728, 577, 634, 576], "text": "SOV"}, {"boundingBox": [742, 526, 824, 525, 824, 577, 742, 577], "text": "and"}, {"boundingBox": [833, 525, 938, 525, 938, 578, 833, 577], "text": "other"}, {"boundingBox": [946, 525, 1154, 524, 1155, 578, 947, 578], "text": "marketing"}, {"boundingBox": [1162, 524, 1352, 523, 1353, 577, 1163, 578], "text": "spending"}, {"boundingBox": [1361, 523, 1486, 522, 1488, 577, 1362, 577], "text": "(DTC,"}, {"boundingBox": [1495, 522, 1588, 522, 1590, 576, 1497, 577], "text": "etc.)"}, {"boundingBox": [1597, 522, 1664, 521, 1666, 575, 1599, 576], "text": "Vs."}]}, {"boundingBox": [324, 580, 575, 579, 576, 621, 325, 623], "text": "competition.", "words": [{"boundingBox": [331, 582, 574, 580, 575, 623, 331, 623], "text": "competition."}]}, {"boundingBox": [283, 640, 470, 643, 469, 683, 282, 681], "text": ">Lantus", "words": [{"boundingBox": [289, 641, 469, 643, 468, 684, 288, 681], "text": ">Lantus"}]}, {"boundingBox": [275, 707, 781, 712, 780, 781, 274, 776], "text": "Other Lilly Drugs", "words": [{"boundingBox": [280, 710, 448, 710, 446, 777, 280, 777], "text": "Other"}, {"boundingBox": [461, 710, 589, 711, 586, 778, 459, 777], "text": "Lilly"}, {"boundingBox": [602, 711, 779, 714, 775, 782, 600, 778], "text": "Drugs"}]}, {"boundingBox": [258, 803, 776, 809, 775, 878, 257, 872], "text": "Potential Upsides", "words": [{"boundingBox": [265, 807, 527, 810, 524, 870, 262, 868], "text": "Potential"}, {"boundingBox": [539, 810, 777, 809, 775, 879, 536, 870], "text": "Upsides"}]}, {"boundingBox": [278, 889, 721, 886, 722, 935, 279, 938], "text": ">45mg Combo Data", "words": [{"boundingBox": [286, 889, 449, 889, 449, 937, 286, 938], "text": ">45mg"}, {"boundingBox": [459, 889, 610, 888, 608, 936, 458, 937], "text": "Combo"}, {"boundingBox": [620, 888, 722, 888, 719, 936, 617, 936], "text": "Data"}]}, {"boundingBox": [282, 954, 1069, 949, 1070, 999, 283, 1005], "text": "> Patient growth continues 2000 trend", "words": [{"boundingBox": [287, 955, 318, 955, 317, 1003, 286, 1002], "text": ">"}, {"boundingBox": [331, 955, 477, 954, 475, 1004, 329, 1003], "text": "Patient"}, {"boundingBox": [486, 954, 629, 953, 627, 1003, 484, 1004], "text": "growth"}, {"boundingBox": [638, 953, 837, 952, 835, 1001, 637, 1003], "text": "continues"}, {"boundingBox": [846, 952, 949, 951, 947, 999, 845, 1001], "text": "2000"}, {"boundingBox": [958, 951, 1070, 951, 1068, 996, 956, 999], "text": "trend"}]}, {"boundingBox": [285, 1015, 950, 1017, 950, 1064, 284, 1063], "text": "` DPP Rezulin results published", "words": [{"boundingBox": [286, 1017, 317, 1017, 317, 1062, 285, 1061], "text": "`", "confidence": "Low"}, {"boundingBox": [329, 1017, 425, 1018, 424, 1063, 329, 1062], "text": "DPP"}, {"boundingBox": [436, 1018, 593, 1019, 592, 1065, 436, 1063], "text": "Rezulin"}, {"boundingBox": [602, 1019, 741, 1019, 740, 1065, 601, 1065], "text": "results"}, {"boundingBox": [750, 1019, 950, 1017, 948, 1064, 748, 1065], "text": "published"}]}, {"boundingBox": [284, 1079, 910, 1081, 909, 1131, 283, 1129], "text": "> Actos vs. Avandia lipid study", "words": [{"boundingBox": [284, 1082, 317, 1082, 317, 1128, 284, 1128], "text": ">"}, {"boundingBox": [329, 1082, 446, 1081, 446, 1129, 329, 1128], "text": "Actos"}, {"boundingBox": [455, 1081, 519, 1081, 518, 1129, 455, 1129], "text": "vs."}, {"boundingBox": [528, 1081, 696, 1081, 696, 1130, 527, 1129], "text": "Avandia"}, {"boundingBox": [705, 1081, 795, 1082, 795, 1131, 705, 1130], "text": "lipid"}, {"boundingBox": [804, 1082, 909, 1083, 909, 1132, 804, 1131], "text": "study"}]}, {"boundingBox": [283, 1141, 1678, 1138, 1679, 1192, 284, 1194], "text": "> Dissemination of medical data favorable to glitazone class/ACTOS", "words": [{"boundingBox": [287, 1146, 317, 1146, 317, 1189, 287, 1188], "text": ">"}, {"boundingBox": [331, 1146, 620, 1146, 620, 1192, 331, 1189], "text": "Dissemination"}, {"boundingBox": [631, 1146, 672, 1146, 672, 1193, 631, 1192], "text": "of"}, {"boundingBox": [681, 1146, 851, 1146, 851, 1194, 680, 1193], "text": "medical"}, {"boundingBox": [860, 1146, 945, 1145, 945, 1194, 859, 1194], "text": "data"}, {"boundingBox": [953, 1145, 1146, 1144, 1146, 1194, 953, 1194], "text": "favorable"}, {"boundingBox": [1154, 1144, 1195, 1144, 1195, 1194, 1154, 1194], "text": "to"}, {"boundingBox": [1206, 1144, 1393, 1142, 1394, 1193, 1206, 1194], "text": "glitazone"}, {"boundingBox": [1402, 1142, 1677, 1139, 1677, 1190, 1402, 1193], "text": "class/ACTOS"}]}, {"boundingBox": [260, 1244, 416, 1246, 417, 1299, 258, 1295], "text": "Gaps", "words": [{"boundingBox": [265, 1243, 416, 1245, 415, 1298, 264, 1296], "text": "Gaps"}]}, {"boundingBox": [282, 1306, 1800, 1310, 1799, 1360, 281, 1357], "text": ">Takeda's decentralized medical efforts and shortage of medical capacity", "words": [{"boundingBox": [288, 1309, 524, 1310, 524, 1357, 289, 1355], "text": ">Takeda's"}, {"boundingBox": [533, 1310, 805, 1311, 806, 1358, 533, 1357], "text": "decentralized"}, {"boundingBox": [815, 1311, 977, 1312, 977, 1359, 815, 1358], "text": "medical"}, {"boundingBox": [986, 1312, 1118, 1312, 1117, 1359, 986, 1359], "text": "efforts"}, {"boundingBox": [1127, 1312, 1206, 1312, 1206, 1360, 1127, 1359], "text": "and"}, {"boundingBox": [1216, 1312, 1396, 1312, 1396, 1360, 1215, 1360], "text": "shortage"}, {"boundingBox": [1405, 1312, 1445, 1312, 1445, 1360, 1405, 1360], "text": "of"}, {"boundingBox": [1454, 1312, 1620, 1311, 1619, 1361, 1454, 1360], "text": "medical"}, {"boundingBox": [1629, 1311, 1800, 1310, 1799, 1361, 1628, 1361], "text": "capacity"}]}, {"boundingBox": [326, 1363, 1202, 1361, 1203, 1411, 327, 1412], "text": "are inhibiting progress in medical initiatives", "words": [{"boundingBox": [333, 1363, 395, 1363, 395, 1413, 333, 1413], "text": "are"}, {"boundingBox": [405, 1363, 592, 1364, 592, 1413, 405, 1413], "text": "inhibiting"}, {"boundingBox": [602, 1364, 782, 1364, 781, 1413, 601, 1413], "text": "progress"}, {"boundingBox": [792, 1364, 831, 1364, 830, 1413, 791, 1413], "text": "in"}, {"boundingBox": [841, 1364, 1001, 1364, 1000, 1412, 840, 1413], "text": "medical"}, {"boundingBox": [1011, 1364, 1201, 1363, 1200, 1410, 1010, 1412], "text": "initiatives"}]}, {"boundingBox": [236, 1445, 314, 1444, 314, 1470, 237, 1471], "text": "AUTO>", "words": [{"boundingBox": [243, 1446, 314, 1444, 313, 1470, 243, 1470], "text": "AUTO>", "confidence": "Low"}]}, {"boundingBox": [101, 1597, 545, 1597, 544, 1626, 100, 1625], "text": "Confidential - Subject to Protective Order", "words": [{"boundingBox": [101, 1597, 226, 1598, 226, 1625, 102, 1626], "text": "Confidential"}, {"boundingBox": [232, 1598, 247, 1598, 247, 1625, 232, 1625], "text": "-"}, {"boundingBox": [253, 1598, 334, 1598, 334, 1624, 253, 1625], "text": "Subject"}, {"boundingBox": [340, 1598, 361, 1598, 360, 1625, 340, 1624], "text": "to"}, {"boundingBox": [366, 1598, 476, 1598, 475, 1626, 366, 1625], "text": "Protective"}, {"boundingBox": [482, 1598, 545, 1598, 543, 1627, 481, 1626], "text": "Order"}]}, {"boundingBox": [1738, 1595, 2012, 1596, 2011, 1625, 1737, 1624], "text": "LLY-HOVENR-00001912", "words": [{"boundingBox": [1742, 1596, 2011, 1597, 2010, 1626, 1742, 1626], "text": "LLY-HOVENR-00001912"}]}, {"boundingBox": [1745, 1629, 2107, 1629, 2107, 1660, 1746, 1661], "text": "Produced in MDL on 02/27/13", "words": [{"boundingBox": [1747, 1631, 1860, 1632, 1860, 1659, 1746, 1661], "text": "Produced"}, {"boundingBox": [1866, 1632, 1889, 1632, 1888, 1659, 1865, 1659], "text": "in"}, {"boundingBox": [1895, 1632, 1953, 1632, 1952, 1659, 1894, 1659], "text": "MDL"}, {"boundingBox": [1958, 1632, 1991, 1632, 1990, 1659, 1958, 1659], "text": "on"}, {"boundingBox": [1997, 1632, 2107, 1629, 2106, 1661, 1996, 1659], "text": "02/27/13"}]}, {"boundingBox": [634, 1694, 1568, 1691, 1569, 1732, 635, 1734], "text": "Source: https://www.induposdiscooogsts.ucsf.edu/docs/ynjf0226", "words": [{"boundingBox": [637, 1697, 750, 1697, 750, 1731, 637, 1730], "text": "Source:"}, {"boundingBox": [756, 1697, 1566, 1692, 1568, 1731, 756, 1731], "text": "https://www.induposdiscooogsts.ucsf.edu/docs/ynjf0226", "confidence": "Low"}]}]}]}